Vaginal RNA Profile Using Molecular Probe (Qualitative/Quantitative Screening)
This test detects specific RNA sequences in vaginal fluid to help assess potential infections or inflammatory conditions, often used in gynecologic evaluations.
["Helps identify possible vaginal infections or health concerns through molecular analysis of RNA."]
Key facts at a glance
- LOINC
- 46154-1
- Short code
- T vaginalis rRNA Spec Ql NAA+probe
- Synonyms
- T vaginalis rRNA Spec Ql NAA+probe
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- probe-amp-tar
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test uses a molecular probe to analyze RNA from vaginal cells. RNA can indicate the presence of certain bacteria, viruses, or inflammatory markers that may suggest infections like *Chlamydia*, *Gardnerella*, or other microbial activity. This is not a traditional blood or urine test but focuses on fluid from the vaginal area.
Why It Might Be Ordered
Your healthcare provider may recommend this test if you have symptoms like unusual discharge, odor, itching, or if you’re at higher risk for sexually transmitted infections (STIs). It can also be part of routine screening for certain conditions in women of reproductive age.
Sample Collection and Process
A healthcare professional will collect a sample of vaginal fluid using a sterile swab. The sample is then processed in a lab to detect RNA sequences associated with specific pathogens or inflammatory responses. Results are qualitative (yes/no presence) or quantitative (relative amount) based on probe detection.
What the Results Mean
Results may show the presence or absence of targeted RNA sequences. A positive result suggests possible infection or inflammation, but further testing (e.g., cultures or additional molecular assays) may be needed for confirmation. Negative results do not rule out infection entirely if symptoms persist.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
Vaginal RNA Test (Screening)
Frequently asked questions
This test is primarily used as a screening tool to identify potential vaginal infections early, which can prevent complications like pelvic inflammatory disease or chronic pelvic pain. Early detection allows for prompt treatment with antibiotics or other therapies tailored to the identified RNA profile.
How long will I need to wait for results?
Can I take anything specific before this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy